789
Participants
Start Date
August 31, 2011
Primary Completion Date
October 31, 2013
Study Completion Date
October 31, 2013
Placebo matching with BMS-820836
Tablet, Oral, 0.0 mg, Once daily, 54 weeks
BMS-820836
Tablet, Oral, 0.5 mg, Once daily, 54 weeks
BMS-820836
Tablet, Oral, 1.0 mg, Once daily, 54 weeks
BMS-820836
Tablet, Oral, 2.0 mg, Once daily, 54 weeks
Local Institution, Vienna
Local Institution, Vienna
Local Institution, Caba
Local Institution, Caba
Local Institution, La Plata
Local Institution, Johannesburg
Local Institution, Heidelberg
Local Institution, Durban
Local Institution, Brisbane
Local Institution, Córdoba
Local Institution, Córdoba
Local Institution, Adelaide
Local Institution, Mendoza
Local Institution, Nedlands
Local Institution, Cape Town
Village Clinical Research, Inc., New York
Spri Clinical Trials, Llc, Brooklyn
Comprehensive Clinical Development, Inc, Jamaica
Neurobehavioral Research, Inc., Cedarhurst
Local Institution, Kungens Kurva
Finger Lakes Clinical Research, Rochester
Bioscience Research, Llc, Pittsburgh
Insite Clinical Research, Pittsburgh
Local Institution, Jonzac
Lehigh Center For Clinical Research, Allentown
Suburban Research Associates, Media
University Of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Keystone Clinical Studies, Llc, Norristown
Local Institution, Turku
Local Institution, Lund
Richard H. Weisler, Md, Pa & Assoc., Raleigh
Local Institution, Madrid
Carolinas Healthcare System, Charlotte
Local Institution, Arganda
Carolina Clinical Research Services, Columbia
Carman Research, Smyrna
Emory University, Atlanta
Atlanta Institute Of Medicine & Research, Atlanta
Comprehensive Clinical Development, Inc, Atlanta
Amit Vijapura, Jacksonville
Clinical Neuroscience Solutions, Inc., Jacksonville
Clinical Neuroscience Solutions, Inc., Orlando
Compass Research, Llc, Orlando
Local Institution, Tampere
Janus Center For Psychiatric Research, West Palm Beach
Stedman Clinical Trials, Tampa
Comprehensive Clinical Development, Inc., St. Petersburg
Gulfcoast Clinical Research Center, Fort Myers
Local Institution, Montpellier
Meridien Research, Brooksville
Birmingham Psychiatry Pharmaceutical Studies, Inc., Birmingham
Psychiatric Consultants, Pc, Franklin
Clinical Neuroscience Solutions, Inc., Memphis
Local Institution, Dole
Neurology & Neuroscience Center Of Ohio, Toledo
Northcoast Clinical Trials, Inc, Beachwood
Patient Priority Clinical Sites, Llc, Cincinnati
Midwest Clinical Research Center, Dayton
Clinco, Terre Haute
Alpine Clinic, Lafayette
Local Institution, Siena
Independent Psychiatric Consultants, Sc, Dba, Ipc Research, Waukesha
Northbrooke Research Center, Brown Deer
Dean Foundation For Health Research & Education, Middleton
Local Institution, Pisa
Local Institution, Douai
Local Institution, Seinäjoki
Loyola University Medical Center, Maywood
Clinical Trials Technology, Inc, Prairie Village
James G. Barbee, Md, Llc, New Orleans
J. Gary Booker, Md, Apmc, Shreveport
K & S Professional Research Services, Llc, Little Rock
Arkansas Psychiatric Clinic Clinical Research Trials, P.A., Little Rock
Ips Research Company, Oklahoma City
Tulsa Clinical Research, Llc, Tulsa
Local Institution, Paris
Futuresearch Trials Of Dallas, Dallas
Grayline Clinical Drug Trials, Wichita Falls
Baylor College Of Medicine, Houston
Ut Health-Houston, Houston
Red Oak Psychiatry Associates, Pa, Houston
San Antonio Psychiatric Research Center, San Antonio
Futuresearch Trials, Austin
Community Clinical Research, Inc., Austin
Local Institution, Élancourt
Western Affiliated Research Institute, Denver
Radiant Research, Inc., Denver
Ericksen Research And Development, Clinton
Psychiatric And Behavioral Solutions, Salt Lake City
Lifetree Clinical Research, Salt Lake City
Radiant Research, Inc., Murray
Local Institution, Limoges
Albuquerque Neuroscience, Inc., Albuquerque
Local Institution, Oulu
Pharmacology Research Institute, Los Alamitos
Pacific Clinical Research Medical Group, Arcadia
Behavioral Research Specialists, Llc, Glendale
Pharmacology Research Institute, Encino
California Neuroscience Research Medical Group, Inc., Sherman Oaks
Schuster Medical Research Institute, Sherman Oaks
Catalina Research Institute, Llc, Chino
Pacific Clinical Research Medical Group, Upland
California Neuropsychopharmacology Clinical, San Diego
Pacific Research Network, San Diego
Affiliated Research Institute, San Diego
Artemis Institute For Clinical Research, San Diego
Sharp Mesa Vista Hospital, San Diego
Anderson Clinical Research, Redlands
Pharmacology Research Institute, Newport Beach
Collaborative Neuroscience Network, Inc., Garden Grove
Neuropsychiatric Research Center Of Orange County, Orange
Pacific Clinical Research Medical Group, Orange
Oregon Center For Clinical Investigations, Inc. (Occi, Inc), Portland
Summit Research Network (Oregon) Inc, Portland
Oregon Center For Clinical Investigations, Inc (Occi, Inc), Salem
Northwest Clinical Research Center, Bellevue
Summit Research Network (Seattle) Llc, Seattle
Local Institution, Mumbai
Local Institution, Pune
Local Institution, Pune
Local Institution, Vishakapattanam
Local Institution, Chennai
Connecticut Clinical Research, Cromwell
Mclean Hospital, Belmont
Bio Behavioral Health, Toms River
Univ Of Penn, Philadelphia
University Of Pennsylvania, Philadelphia
Comprehensive Psychiatric Care, Pittsburgh
Lincoln Research, Lincoln
Neuropsychiatric Associates, Woodstock
Local Institution, Helsinki
Local Institution, Helsinki
Local Institution, Järvenpää
Local Institution, Ahmedabad
Local Institution, Varanasi
Local Institution, Ponce
Local Institution, Pretoria
Local Institution, Pretoria
Local Institution, Pretoria
Local Institution, Barcelona
Local Institution, Barcelona
Local Institution, Halmstad
Local Institution, Uppsala
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY